{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:59:43Z","timestamp":1781657983888,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.contraception.2010.09.002","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T09:35:43Z","timestamp":1287480943000},"page":"410-417","source":"Crossref","is-referenced-by-count":52,"title":["Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone"],"prefix":"10.1016","volume":"83","author":[{"given":"Nguyen Thi Nhu","family":"Ngoc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Bach","family":"Nga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Dabash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayisha","family":"Diop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Winikoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.09.002_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2004.07.011","article-title":"The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion","volume":"71","author":"Creinin","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0010","unstructured":"Concept Foundation website for Medabon: http:\/\/www.medabon.info\/ accessed February 6, 2010."},{"key":"10.1016\/j.contraception.2010.09.002_bb0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijgo.2008.12.016","article-title":"Assessing the global availability of misoprostol","volume":"105","author":"Fernandez","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2010.09.002_bb0020","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2010.09.002_bb0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","article-title":"Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial","volume":"107","author":"World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2010.09.002_bb0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bmj.307.6903.532","article-title":"Termination of pregnancy with reduced doses of mifepristone","volume":"307","author":"World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2010.09.002_bb0035","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2004.00209.x","article-title":"Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multi-centre study in Vietnam","volume":"111","author":"Ngoc","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2010.09.002_bb0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(01)00229-3","article-title":"Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion","volume":"64","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0045","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial","volume":"284","author":"Schaff","year":"2000","journal-title":"JAMA"},{"issue":"5 Pt 1","key":"10.1016\/j.contraception.2010.09.002_bb0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.AOG.0000124271.23499.84","article-title":"MOD study trial group. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion","volume":"103","author":"Creinin","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.09.002_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.contraception.2004.12.013","article-title":"A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days","volume":"71","author":"Schreiber","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0060","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion. A randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.09.002_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2008.09.001","article-title":"Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol","volume":"79","author":"Raghavan","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/17474108.2.1.67","article-title":"Misoprostol for uterine evacuation in induced abortion and pregnancy failure","volume":"2","author":"Clark","year":"2007","journal-title":"Expert Rev Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.09.002_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-7824(02)00366-9","article-title":"Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy","volume":"66","author":"Schaff","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimens for medical abortion","volume":"361","author":"Fjerstad","year":"2009","journal-title":"N Eng J Med"},{"key":"10.1016\/j.contraception.2010.09.002_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.contraception.2004.03.007","article-title":"Misoprostol as the primary agent for medical abortion in a low income urban settings","volume":"70","author":"Borgatta","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(97)00020-6","article-title":"The use of misoprostol for termination of early pregnancy","volume":"55","author":"Carbonell","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/13625189709167474","article-title":"The use of misoprostol for abortion at < or =9 weeks' gestation","volume":"2","author":"Carbonell","year":"1997","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2010.09.002_bb0100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1471-0528.2007.01274.x","article-title":"Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8,678 cases","volume":"114","author":"Aldrich","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2010.09.002_bb0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.contraception.2005.02.008","article-title":"Misoprostol alone for early abortion: an evaluation of seven potential regimens","volume":"72","author":"Blanchard","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0110","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(07)60914-3","article-title":"Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled trial","volume":"369","author":"von Hertzen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.09.002_bb0115","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/17.6.1477","article-title":"A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy","volume":"17","author":"Jain","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2010.09.002_bb0120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.contraception.2004.06.014","article-title":"Comparison of misoprostol plasma concentrations following buccal and sublingual administration","volume":"71","author":"Schaff","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2010.09.002_bb0125","first-page":"S160","article-title":"Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"IJGO"},{"issue":"3 Pt 1","key":"10.1016\/j.contraception.2010.09.002_bb0130","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.AOG.0000230398.32794.9d","article-title":"Misoprostol administered by epithelial routes: drug absorption and uterine response","volume":"108","author":"Meckstroth","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2010.09.002_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2950750","article-title":"Abortion in context: women's experience in two villages in Thai Bihn Province, Vietnam","volume":"22","author":"Johansson","year":"1996","journal-title":"Fam Plann Perspec"},{"key":"10.1016\/j.contraception.2010.09.002_bb0140","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2010.09.002_bb0145","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2010.09.002_bb0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0020-7292(01)00567-7","article-title":"Misoprostol use in obstetrics and gynecology in Brazil, Jamaica, and the United States","volume":"76","author":"Clark","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2010.09.002_bb0155","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1471-0528.2005.00704.x","article-title":"Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republic: a temporal association","volume":"112","author":"Miller","year":"2005","journal-title":"BJOG"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410005226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410005226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T05:21:33Z","timestamp":1544160093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410005226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0010782410005226"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.09.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10320956.11131054","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}